These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 6801612
1. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB. Hechtman P, Gordon BA, Ng Ying Kin NM. Pediatr Res; 1982 Mar; 16(3):217-22. PubMed ID: 6801612 [Abstract] [Full Text] [Related]
3. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein. Inui K, Grebner EE, Jackson LG, Wenger DA. Am J Hum Genet; 1983 Jul; 35(4):551-64. PubMed ID: 6224417 [Abstract] [Full Text] [Related]
4. Interaction of activating protein and surfactants with human liver hexosaminidase A and GM2 ganglioside. Hechtman P, Kachra Z. Biochem J; 1980 Mar 01; 185(3):583-91. PubMed ID: 7387624 [Abstract] [Full Text] [Related]
5. Substrate binding properties of the human liver hexosaminidase A activator protein. Hechtman P, Isaacs C, Smith-Jones L. Can J Biochem Cell Biol; 1985 Aug 01; 63(8):830-8. PubMed ID: 2933135 [Abstract] [Full Text] [Related]
7. The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis. Hirabayashi Y, Li YT, Li SC. J Neurochem; 1983 Jan 01; 40(1):168-75. PubMed ID: 6848657 [Abstract] [Full Text] [Related]
8. Assay of ganglioside GM2-N-acetyl-beta-D-galactosaminidase activity in human fibroblasts employing the natural activator protein--diagnosis of variant forms of GM2 gangliosidosis. Erzberger A, Conzelmann E, Sandhoff K. Clin Chim Acta; 1980 Dec 22; 108(3):361-8. PubMed ID: 6781795 [Abstract] [Full Text] [Related]
9. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses. Charrow J, Binns HJ. Clin Chim Acta; 1986 Apr 15; 156(1):41-9. PubMed ID: 2938852 [Abstract] [Full Text] [Related]
10. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2. Conzelmann E, Burg J, Stephan G, Sandhoff K. Eur J Biochem; 1982 Apr 01; 123(2):455-64. PubMed ID: 6210531 [Abstract] [Full Text] [Related]
11. Biochemical basis of type AB GM2 gangliosidosis in a Japanese spaniel. Ishikawa Y, Li SC, Wood PA, Li YT. J Neurochem; 1987 Mar 01; 48(3):860-4. PubMed ID: 2949061 [Abstract] [Full Text] [Related]
12. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level. Conzelmann E, Kytzia HJ, Navon R, Sandhoff K. Am J Hum Genet; 1983 Sep 01; 35(5):900-13. PubMed ID: 6614006 [Abstract] [Full Text] [Related]
14. Characterization of an activating factor required for hydrolysis of Gm2 ganglioside catalyzed by hexosaminidase A. Hechtman P. Can J Biochem; 1977 Apr 01; 55(4):315-24. PubMed ID: 858083 [Abstract] [Full Text] [Related]
17. Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A. Kytzia HJ, Sandhoff K. J Biol Chem; 1985 Jun 25; 260(12):7568-72. PubMed ID: 3158659 [Abstract] [Full Text] [Related]
19. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant). Conzelmann E, Nehrkorn H, Kytzia HJ, Sandhoff K, Macek M, Lehovský M, Elleder M, Jirásek A, Kobilková J. Pediatr Res; 1985 Nov 25; 19(11):1220-4. PubMed ID: 2933632 [Abstract] [Full Text] [Related]